Literature DB >> 34328108

Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.

Mukta Agrawal1, Shailendra Saraf2, Madhulika Pradhan1, Ravish J Patel3, Gautam Singhvi4, Amit Alexander5.   

Abstract

Herbal antioxidant like curcumin holds great potential to treat neurodegenerative disease like Alzheimer's disease. However, its therapeutic potency is obstructed due to rapid metabolism, poor solubility, GI susceptibility, enzymatic degradation and lower bioavailability. Thus, the present work aimed to design and optimize curcumin-loaded NLC (CNL) with higher drug entrapment, prolonged release and better stability. CNL was prepared by modified melt emulsification method followed by ultrasonication. The formulation was optimized by 3 factor 3 level Box-Behnken design using solid: liquid lipid, surfactant concentration and ultrasonication time as independent variable while particle size, entrapment efficiency and % drug release as dependant variable. The design suggested 3.092 solid:liquid lipid, 2.131% surfactant and 4.757 min ultrasonication fit best to get the optimized formulation. The size of the optimized CNL was noted 124.37 ± 55.81 nm, which is in the acceptable range for brain delivery. SEM results also comply with this size range (near 150 nm) and demonstrated almost spherical and uniform particles with porous and uneven surface structures. PDI, zeta potential, entrapment efficiency and % drug release were observed as 0.201 ± 0.00, - 17.2 ± 2.35 mV, 93.62 ± 0.68% and 92.73 ± 0.06%, respectively. The NLC demonstrated initial burst release with subsequent prolonged release of drug for 48 h. Weibull kinetic equation with 0.9958 R2, minimum AIC and maximum MSC value was found best fit to explain the release behavior. The β exponent and diffusional coefficient (n) indicated combined release mechanism with Fickian diffusion as drug release mechanism. Formulation was also found stable at different storage condition.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Box-Behnken design; Curcumin; Nano lipid carrier; Release kinetics

Mesh:

Substances:

Year:  2021        PMID: 34328108     DOI: 10.1016/j.biopha.2021.111919

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders.

Authors:  Sakshi Buchke; Muskan Sharma; Anusuiya Bora; Maitrali Relekar; Piyush Bhanu; Jitendra Kumar
Journal:  Life (Basel)       Date:  2022-04-29

2.  Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin.

Authors:  Heba S Elsewedy; Tamer M Shehata; Mervt M Almostafa; Wafaa E Soliman
Journal:  Nanomaterials (Basel)       Date:  2022-06-23       Impact factor: 5.719

Review 3.  An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor.

Authors:  Ali Sartaj; Zufika Qamar; Shadab Md; Nabil A Alhakamy; Sanjula Baboota; Javed Ali
Journal:  Front Bioeng Biotechnol       Date:  2022-02-03

4.  Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects.

Authors:  Saleha Rehman; Bushra Nabi; Amaan Javed; Tahira Khan; Ashif Iqubal; Mohammad Javed Ansari; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.